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There is substantial evidence that ultraviolet radiation
induces the formation of reactive oxygen species
which are implicated as toxic intermediates in the
pathogenesis of photoaging. The aim of this study was
to determine whether repeated topical treatment with
benzoyl peroxide, a source of free radicals, produced
the same cutaneous effects as chronic ultraviolet B
radiation. Three concentrations of benzoyl peroxide
(0.1, 1.5, 5.0% wt/wt) and three cumulative fluences
of ultraviolet B radiation (0.9, 2.2, 5.1 J per cm2) used
alone and in all combinations along with appropriate
controls. Female SKH1 (hr/hr) albino hairless mice
were treated 5 d per wk for 12 wk. Extracellular matrix
molecules and histologic parameters were assessed.
Ultraviolet B radiation induced a fluence-dependent
and time-dependent increase in skin-fold thickness.
Fluence dependence was seen for epidermal thickness,
sunburn cell numbers, dermal thickness, glycosamino-
Chronic exposure of skin to ultraviolet radiation(UVR) produces multiple deleterious responsesincluding the morphologic changes termed photo-aging (Gilchrest, 1996). The manifestations ofphotoaged human skin, such as deep wrinkling,
coarseness, and yellow coloration, are accompanied by marked
alterations in the structure and composition of the dermis. The
papillary dermis, in particular, appears to reflect this constant damage
with an increased content of amorphous elastin (solar elastosis),
structural disorganization of collagen, and an increase in ground
substance. The presence of a peri-venular, lymphohistiocytic dermal
infiltrate supports the suggestion that photoaging is a chronic
inflammatory condition (Lavker and Kligman, 1988). The causal
association of chronic UV exposure with epidermal and dermal
pathophysiology in humans is strongly supported by studies in an
animal model for photoaging, the chronically UV-exposed hairless
mouse (Kligman et al, 1982; Bissett et al, 1987). Specifically,
increases in elastin, glycosaminoglycans (GAG), and mast cells, and
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glycan content, mast cell numbers, and skin-fold thick-
ness. Benzoyl peroxide treatment alone caused less
marked increases in epidermal and dermal measures
compared with ultraviolet B under the conditions
used. A benzoyl peroxide concentration-dependent
increase was only observed for elastin content,
although the highest concentration of benzoyl perox-
ide increased epidermal thickness and glycosamino-
glycan content. A synergistic interaction between
ultraviolet B and benzoyl peroxide was not found.
These results indicate that repeated administration of
benzoyl peroxide produces skin changes in the hairless
mouse that qualitatively resemble those produced by
ultraviolet B and suggest that common mechanisms
may be involved. In addition, any potential synergistic
effect of ultraviolet B and benzoyl peroxide was below
the level of detection used in this study. Key words:
benzoyl peroxide/extracellular matrix/photoaging/photo-
biology. J Invest Dermatol 112:933–938, 1999
the appearance of activated fibroblasts and an inflammatory infiltrate
are produced, similar to the changes seen in human photoaging.
The processes believed to initiate photoaging include the primary
photoreactions of cellular chromophores and the formation of
reactive chemical species. DNA photoproducts are implicated in
UV carcinogenesis and may be significant in the pathogenesis of
photoaging. For example, DNA appears to be the chromophore
for ultraviolet B (UVB) induced production of interleukin-6, a
cytokine involved in local inflammation (Petit-Fre´re et al, 1998).
In addition, recent work has shown that non-DNA chromophores
initiate intracellular signaling pathways for gene activation by the
production of radicals that alter plasma membrane receptors (Knebel
et al, 1996). The transcription factors induced by these processes
are involved in the production of inflammatory mediators in the
skin and, thus, may also be important in the photoaging mechanisms.
Experiments in animals indicate that inflammation is a prerequisite
for the development of the changes seen in photoaging. For
example, anti-inflammatory agents (Bissett et al, 1990a; Kochevar
et al, 1993), anti-oxidants and free radical scavenging agents (Bissett
et al, 1990b, c; Record et al, 1991), and iron chelators (Bissett
et al, 1991) inhibit chronic UVB-induced changes in mouse skin,
although inhibition is not seen with β-carotene (Kligman and
Mathews-Roth, 1990). Other chronic physical insults, such as heat
and ionizing radiation, induce inflammation and produce increased
accumulation of elastotic material in the dermis (Johnson and
Butterworth, 1971; Kligman and Kligman, 1984). The specific
inflammatory mediators present, however, appear to influence
strongly tissue remodeling in photoaged skin because most chronic
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inflammatory skin diseases, such as psoriasis and atopic dermatitis,
are not associated with elastosis. As UVR (Jurkiewicz and Buettner,
1994, 1996) and ionizing radiation produce free radicals in tissue,
and radical scavenging agents reduce free radical levels in tissue
(Jurkiewicz et al, 1995; Jurkiewicz and Buettner, 1996) as well as
inhibiting photoaging, free radical production may be a common
intermediate step in the process(es) that initiate tissue damage
leading to photoaged skin.
This study was undertaken to determine whether chronic
exposure to a source of free radicals would produce the changes
in hairless mouse skin characteristic of chronic UVB exposure.
Benzoyl peroxide (BPO) was chosen as the source of free radicals
in this study because it breaks down to produce a benzoyloxy
radical that can abstract a hydrogen to form benzoic acid or
decarboxylate to form a phenyl radical (Binder et al, 1995). Both
of the radicals are highly reactive. In addition, BPO absorbs short
wavelength UVR in solution and breaks down to form two
benzoyloxy radicals (Nakata et al, 1967); whether this reaction
occurs in tissue is not known. The interaction between UVB and
BPO on epidermal and dermal measures was assessed. The effect
of treatments with UVB, BPO, and combinations of these agents
was determined quantitatively by assessment of epidermal and
dermal histologic and biochemical parameters.
MATERIALS AND METHODS
Mice Female, albino hairless mice [Cr1:SKH1 (hr/hr)] from Charles
Rivers Laboratories were used. The animals were 6–7 wk old at the
beginning of the experiment. Mice were identified by ear punches and
housed in groups of four per cage.
Materials BPO carbopol gels (USP) were used as 0.1%, 1.5%, and 5.0%
(wt/wt) suspensions. Desmosine antiserum and Bolton Hunter-labeled
desmosine were obtained from Elastin Products Co. (Owensville, MO).
Goat antirabbit antiserum was from Organon Teknika Corp. (West Chester,
PA). Glucuronic acid lactone, papain, sodium acetate, cysteine, Bis-Tris
buffer, polyethylene glycol, chloramine T, and 4-hydroxyproline were
obtained from Sigma (St. Louis, MO). Sodium tetraborate and perchloric
acid were from Fisher (Pittsburgh, PA) and 4-dimethylaminobenzaldehyde
was from Aldrich (Milwaukee, WI).
UVB radiation source A bank of 12 UVB fluorescent tubes (Ho-90°;
Elder Pharmaceuticals) filtered with Kodacel was used. The spectrum is
µ75% between 290 and 320 nm and µ25% at wavelengths longer than
320 nm. Mice were irradiated, four per cage, through a wide-spaced wire
grill. The height of the bulbs was adjusted to deliver 0.5 mW per cm2 at
the dorsal surface of the mice in the cage and the time was adjusted to
deliver the appropriate UVB daily fluence. The irradiance was measured
daily with an IL-1700 research radiometer equipped with a SED 240 UVB
detector (International Light, Newburyport, MA). The spectrum of the
filtered bulbs was measured with a spectroradiometer (Model 742 Optronix
Laboratories Inc., Orlando, FL).
Chronic treatment protocol Three concentrations of BPO and three
fluences of UVB radiation were used in all combinations plus the appropriate
BPO alone, UVB alone, and vehicle controls. An additional group received
no treatment. This resulted in 17 groups including controls. Each group
consisted of eight mice and received 12 wk of five times per week
treatment. The back and sides of each mouse, µ20 cm2, were treated with
100 µl of either 0% (vehicle), 0.1%, 1.5%, or 5% wt/wt BPO carbopol
gel 30 min before UV exposure. The three UVB fluence groups were
defined as: UVB-low, UVB-medium, and UVB-high. UVB-low received
a constant daily fluence of 15 mJ per cm2, resulting in a cumulative fluence
of 0.9 J per cm2. UVB-medium received a constant daily fluence of 37 mJ
per cm2, resulting in a cumulative fluence of 2.2 J per cm2 (the mid-point,
on a log scale, between the groups receiving UVB-low and UVB-high
fluences). The UVB-high group received a cumulative fluence of 5.1 J
per cm2; the daily fluence was increased as the animals tolerated increased
irradiation times: week 1 (15 mJ per cm2), week 2 (30 mJ per cm2), week
3 (50 mJ per cm2), weeks 4 and 5 (80 mJ per cm2), and weeks 6–12
(110 mJ per cm2).
Skin preparation and biochemical assays The protocols used to
measure desmosine, uronic acid, and hydroxyproline were identical to
those used previously (Kochevar et al, 1993). Briefly, after ether euthanasia
the back skin of each mouse was removed and spread on a sheet of dental
wax. For desmosine and hydroxyproline assays, a single 4 mm punch was
taken, hydrolyzed in 6 M HCl at 110°C for 24 h and then evaporated to
dryness at 55°C under nitrogen and dried in a vacuum overnight. Desmosine
was measured by a modification of the radioimmunoassay method of
Starcher (1977). After incubation overnight of the re-dissolved hydrolysate
with probe and antibody solution, 100 ml of goat antirabbit antiserum was
added and incubated at 4°C for 2 h. Polyethyleneglycol (MW 8000, 15%,
100 ml) was added and the mixture centrifuged at 2000 3 g for 1 h. The
radioactivity of the pellets was measured in a LKB 1272 gamma counter.
Hydroxyproline was assayed by a modification of the method of
Stegemann and Stalder (1967). Five hundred milliliters of chloramine T
(1.41%) was added to hydrolysate in 0.2 M sodium acetate buffer (pH 6)
with n-propanol (1:3 vol/vol). The mixture was incubated at room
temperature for 20 min, 500 ml p-dimethylaminobenzaldehyde in n-
propanol (1:4 wt/vol) with perchloric acid, was added, mixed, and
incubated at 60°C for 15 min. Absorbance at 550 nm was measured. Three
6 mm punches were taken for uronic acid measurement. The skin biopsies
were digested in papain (1 mg per ml papain, 5 mM cysteine, 5 mM
ethylenediamine tetraacetic acid in sodium acetate, pH 6) overnight at
60°C, centrifuged at 500 3 g for 20 min, and the aqueous layer was
dialyzed against water before employing the colorimetric assay of Bitter
and Muir (1962). The samples were boiled in 0.025 M sodium tetraborate
in concentrated sulfuric acid. After cooling, 100 ml 0.125% carbazole in
95% ethanol was added and the tubes boiled for 15 min. After cooling,
absorbance at 530 nm was measured.
Histology Skin punches were fixed in formaldehyde-cetyl-pyridinium
chloride. Four micrometer sections were cut from paraffin blocks and
stained with hematoxylin and eosin for measuring epidermal and dermal
thickness and counting dyskeratotic [sunburn/dyskeratotic cells (SBC)]
cells. Resorcin fuchsin-stained sections were used for counting mast cells
and evaluating elastosis. Epidermal and dermal thickness was measured
with an ocular micrometer. Sunburn cells were counted using an eyepiece
micrometer with a 10 3 10 square grid (0.25 mm per side). The micrometer
was aligned with the dermo–epidermal junction and dyskeratotic cells
within the grid were counted. An average of 10 separate fields were
counted for each section and three sections per group were counted. Mast
cells were counted on resorcin fuchsin-stained sections using the same
method. Four animals from each group were assessed. Histologic assessment
and biochemical assays were performed at the end of the treatment period.
All assessments were performed observer blinded.
Skin-fold thickness Mice were lightly anesthetized by Metofane inhala-
tion. The dorsal skin was lifted up by pinching gently and the thickness
of the fold was measured at a nearby area using a spring-loaded dial gauge
micrometer (Fowler, Biggsfield, U.K.). Skin-fold thickness (SFT) was
measured every 2 wk for the duration of the study.
Absorption spectrum of BPO BPO is very slightly soluble in aqueous
solution and moderately soluble in polar organic solvents suggesting that
it will reside in polar lipid regions of cells. The absorption spectrum of
BPO was measured in acetonitrile, a polar organic solvent, because the
long wavelength absorption band of BPO varies with solvent.
Statistical analysis Experimental data were analyzed with a two-way
analysis of variance (ANOVA). Main effects of BPO and UVB and their
interaction were considered statistically significant at p , 0.05. Post hoc
analysis of individual treatment groups was conducted using Student–
Newman–Keuls. Data points in the figures are presented as mean 6 SD
RESULTS
Chronic UVB-induced fluence-dependent responses In this
study, three cumulative fluences of UVB (0.9, 1.5, and 5.1 J per
cm2) were used and the results were compared with an age-
matched control group treated with vehicle for the same duration. In
general, mouse skin treated with the carbopol gel vehicle did not
differ from that receiving no treatment. The exceptions were that
vehicle-treated mice had greater numbers of SBC, 2.8 6 0.1 cells
per µm, and mast cells, 206 6 67 cells per mm2, than those
receiving no treatment 1.2 6 0.6 cells per µm and 184 6 42 cells
per mm2, respectively (p , 0.05).
There was a significant (p , 0.001) effect of UVB on the two
measures of epidermal response, thickness, and number of SBC
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Figure 1. Responses of hairless mouse skin to 12 wk treatment
with three fluences of UVB radiation. UVB treatment was five times
per week for 12 wk. There were four treatment groups: no UVB, vehicle
only; UVB-low, cumulative fluence 0.9 J per cm2; UVB-med, 2.2 J per
cm2; UVB-high, 5.1 J per cm2. Histologic and biochemical assessments
were made on skin punches at 12 wk. (A) Epidermal thickness measured
from dermoepidermal junction to top of stratum granulosum (hematoxylin
and eosin) (µm). (B) SBC number per µm of epidermal cross-section
(hematoxylin and eosin). (C) Elastin measured as desmosine per area of
skin (pmol per cm2). (D) GAG measured as uronic acid per area of skin
(µg per cm2). (E) Dermal thickness measured from dermoepidermal
junction to top of subcutaneous fat (hematoxylin and eosin) (µm). (F)
Mast cell number per mm2 of cross-section of skin from dermoepidermal
junction to top of subcutaneous fat. *p , 0.05; compared with no UVB
treatment group.
(Fig 1A, B). For both measures, the increase was fluence dependent.
UVB exposure had a significant (p , 0.001), fluence-dependent
effect on measures of dermal response including GAG, mast cells,
and dermal thickness (Fig 1D–F). No effect was observed for
collagen (data not shown), and the relationship between UVB
exposure and elastin was significant (p , 0.001), but did not show
a simple fluence dependence (Fig 1C). SFT determined at intervals
over the 12 wk of treatment, increased as a function of time and
fluence of UVB (p , 0.001) (Fig 2).
Chronic BPO treatment There was a trend toward an increase
in epidermal thickness (Fig 3A) in response to BPO treatment but
this failed to reach statistical significance (p , 0.054). Likewise,
there was a trend toward an increase in dermal thickness with
increasing BPO concentration, but this also failed to reach
statistical significance (Fig 3B). BPO treatment produced a signific-
ant (p , 0.001), concentration-dependent increase in elastin as
measured by desmosine (Fig 3C). A significant correlation between
BPO dose and GAG content was not found, although the highest
dose of BPO produced a significant (p , 0.5) increase over the
untreated control. Collagen content, SBC number, and mast cell
number were unchanged by BPO treatment (data not shown); SFT
was also unrelated to BPO treatment (Fig 2).
Interaction between UVB and BPO If UVB enhanced the
formation of benzoyloxy radical under the conditions of this
experiment, then a synergistic interaction of these two independent
variables would be anticipated. This was not found. Neither
epidermal thickness (Fig 4A) nor SBC number (Fig 4B) were
Figure 2. Time course of changes in SFT during 12 wk treatment
with UVB, BPO, and combinations of the two treatments. UVB
treatment was five times per week for 12 wk: UVB-low, cumulative
fluence 0.9 J per cm2; UVB-med, 2.2 J per cm2; UVB-high, 5.1 J per
cm2. Treatment was combined with BPO at 0% (vehicle only), 0.1%,
1.5%, or 5% and a ‘no treatment’ control resulting in 15 treatment groups.
SFT was measured at 2 wk intervals using a spring-loaded micrometer.
affected by the interaction between UVB and BPO, although there
was a nearly statistically significant effect in both cases (p , 0.055
for SBC and p , 0.076 for epidermal thickness). The interaction
between UVB and BPO on measures of elastin (Fig 4C), GAG
content (Fig 4D), and dermal thickness (Fig 4E) was statistically
significant, but complex. For elastin, the interaction was antagonistic
rather than synergistic (p , 0.001). The lowest UVB fluence
combined with either 1.5 or 5% BPO produced much smaller
increases in elastin than UVB alone. Similarly, all three BPO
concentrations significantly reduced the increase in elastin produced
by the medium fluence of UVB. The highest UVB fluence
produced a smaller elastin increase than that of other UVB-treated
groups and BPO alone increased elastin content (Fig 3B). A
somewhat similar trend was observed for GAG content. There was
a significant (p , 0.002) interaction between UVB and BPO in
which the highest concentration of BPO diminished the UVB-
induced increase in GAG. Although there was a significant
(p , 0.014) interaction between UVB and BPO on dermal
thickness, this relationship was complex as well with no consistent
trend observed. Finally, for mast cell number (Fig 4F), and SFT
(Fig 2) there was no interaction between the two independent
variables.
Absorption spectrum of BPO in solution It was anticipated
that the combined treatment of UVB and BPO could induce the
production of additional radicals that might initiate photodamage
because the absorption spectrum of BPO extends into the UVB
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region. Figure 5 shows the absorption spectrum of 0.2 mM BPO
in acetonitrile and the UVB component of the emission spectrum
of the Kodacel-filtered UVB fluorescent lamps used in these studies.
These spectra illustrate that the overlap is relatively minor.
DISCUSSION
There is ample evidence that UVR, both UVB and UVA, induce
toxic free radical intermediates which have been implicated in the
pathogenesis of photoaging (Black, 1987). Studies with animal
models have shown that the clinical and histologic changes of
photoaging can be retarded by prior application of anti-oxidants
and singlet oxygen and superoxide scavenging agents (Bissett et al,
1990b,c; Record et al, 1991). Furthermore, topical application of
iron-chelating agents in murine skin has been shown to delay
UVB-induced photoaging, presumably by decreasing iron-catalyzed
formation of radicals (Bissett et al, 1991). Free radical formation in
skin induced by UVB radiation is also inhibited by anti-oxidants
(Jurkiewicz et al, 1995) and an iron chelator (Jurkiewicz and
Buettner, 1996).
Reactive oxygen species have been shown to cause changes
in vitro which are similar to some of the observed abnormalities
seen in photoaged human skin. For example, in cultured human
fibroblasts, reactive oxygen species cause an increase in GAG and
reduction in collagen (Tanaka et al, 1993). UVR also alters the
Figure 3. Responses of hairless mouse skin to 12 wk treatment
with three concentrations of BPO. BPO treatment was five times per
week for 12 wk. There were four treatment groups: 0% BPO, vehicle
only; 0.1% BPO; 1.5% BPO; and 5% BPO. Histologic and biochemical
assessments were made on skin punches at 12 wk. (A) Epidermal thickness
measured from dermoepidermal junction to top of stratum granulosum
(hematoxylin and eosin) (µm). (B) Dermal thickness measured from
dermoepidermal junction to top of subcutaneous fat (hematoxylin and
eosin) (µm). (C) Elastin measured as desmosine per area of skin (pmol per
cm2). (D) GAG measured as uronic acid per area of skin (µg per cm2)
(n.a. 5 not available; samples lost during processing). *p , 0.05; compared
with 0% BPO treatment group.
Figure 4. Effect of BPO concentration on UVB-induced responses
in hairless mouse skin. UVB treatment was five times per week for
12 wk: no UVB, vehicle only; UVB-low, cumulative fluence 0.9 J per
cm2; UVB-med, 2.2 J per cm2; and UVB-high, 5.1 J per cm2. Treatment
was combined with BPO at 0%, 0.1%, 1.5%, or 5% and resulting in 16
treatment groups. Histologic and biochemical assessments were made
on skin punches at 12 wk. (A) Epidermal thickness measured from
dermoepidermal junction to top of stratum granulosum (H&E) (µm). (B)
SBC number per µm of epidermal cross-section (hematoxylin and eosin).
(C) Elastin measured as desmosine per area of skin (pmol per cm2). (D)
GAG measured as uronic acid per area of skin (µg per cm2). (E) Dermal
thickness measured from dermoepidermal junction to top of subcutaneous
fat (hematoxylin and eosin) (µm). (F) Mast cell number per mm2 of cross-
section of skin from dermoepidermal junction to top of subcutaneous fat.
Statistically significant differences are as shown in Figs 1 and 3.
VOL. 112, NO. 6 JUNE 1999 CHRONIC BPO AND EFFECTS ON MURINE SKIN 937
balance of cutaneous anti-oxidants, and even low fluence UVR has
been shown to deplete cutaneous anti-oxidants such as superoxide
dismutase, with marked reduction in anti-oxidant capacity at higher
fluences and with chronic exposure (Maeda et al, 1991; Shindo
et al, 1994). Overall, this state of increased free radical generation and
reduced anti-oxidant capacity, caused by chronic UVR exposure,
increases oxidative stress that in turn may be implicated in the
inflammatory process, which seems to be essential for the develop-
ment of cutaneous photoaging (Bissett et al, 1990a; Kochevar et al,
1993, 1994).
In skin, BPO breaks down into benzoic acid. A reactive
intermediate, benzoyloxy radical, forms in the process and may
decarboxylate to form another radical, the phenyl radical. Both the
benzoyloxy and phenyl radicals are highly reactive (Binder et al,
1995). BPO induces oxidative stress in vitro (Perchellet et al, 1986;
Babich et al, 1996) which is believed to result in pro-mutagenic
DNA damage and strand breaks (Akman et al, 1992, 1993) via
formation of benzoyloxyl (Swauger et al, 1990) and hydroxyl
(Greenley and Davies, 1993) radicals. In mouse skin, BPO has been
shown to induce oxidative stress, measured by chemiluminescence
(Duran and de Rey, 1991), which is also thought to play a
mechanistic role in tumor promotion (Klein-Szanto and Slaga,
1982) and progression (Athar et al, 1989). In this regard, anti-
oxidants inhibit skin tumor promotion by BPO supportive of a
role of free radicals in this response (Athar et al, 1990). Despite this
evidence, BPO gel did not enhance UV tumorigenesis in hairless
mice in two studies (Iversen, 1986; 1988).
This study has shown that chronic treatment with BPO produces
cutaneous effects similar to those in UVB-photoaged mouse skin.
These effects were only mild, however; the highest concentration
of BPO caused changes which were similar to those produced by
the lowest fluence of UVB alone. For example, 5% BPO produced
maximal epidermal and dermal thicknesses of 35 6 4 and
142 6 11 µm, respectively. These values were comparable with
the respective epidermal and dermal thicknesses seen in the lowest
UVB treatment group (31 6 3 and 173 6 11 µm) (Figs 1A, E
and 3A, B). These values are not the maximum achievable as
treatment with higher UVB fluences increased the thickness of
both skin layers. A similar result is obtained when the changes in
elastin (measured as desmosine) and GAG (measured as uronic acid)
are compared. The elastin content was increased 2-fold by 5%
BPO treatment and 2.7-fold by the lowest UVB fluence (Figs 1C
and 3C); the GAG content increased 3-fold by 5% BPO treatment
and 3.2-fold by low UVB treatment (Figs 1D and 3D). Neither
the number of sunburn cells or mast cells was increased by BPO
treatment (data not shown), although fluence-dependent increases
were observed in the murine skin treated with UVB (Figs 1B, F).
Figure 5. Overlap of absorption spectrum of BPO and emission
spectrum of UVB light source. Absorption spectrum of 0.2 mM BPO
solution in acetonitrile is shown on the left. The UVB portion of the
Kodacel-filtered fluorescent lamps is shown on the right.
The similarities between the results of these two treatments suggest
that the inflammatory mediators induced by UVB-derived and
BPO-derived radicals may be similar but they likely differ from
those involved in chronic skin diseases such as psoriasis and atopic
dermatitis. In contrast, marked differences in the magnitude of the
responses to BPO and UVB treatments were found; the responses
to the highest UVB fluence were greater than to the highest
BPO concentration. Possible explanations for the differences in
magnitude of responses may include either a greater number of
radicals produced by UVB, under the conditions used, than by the
concentration of BPO used, or greater reactivity of the UVB-
induced radical species. Furthermore, different tissue or subcellular
location of radicals produced by the two types of treatment may
dictate the relative effectiveness of higher UVB fluences compared
with BPO treatment for induction of the observed responses.
We anticipated that the oxidative stress caused by UVB and by
free radical generation from BPO would act synergistically when
treatments were combined for two reasons. First, we have shown
in vitro that the oxidative insult caused by UVA can be amplified
by the presence of BPO (Ibbotson et al, 1998). Second, UV-
induced decomposition of BPO was expected to generate and
amplify radical production because there is overlap of the BPO
absorption spectrum with the UVB lamp emission spectrum (Fig 5).
The findings of this study show that combined treatment with
BPO and UVB resulted in no synergism or changes for any of the
parameters studied that were quantitatively greater than to the sum
of the effects of the separate treatments (Fig 4). This would suggest
that the combined treatment regimens did not cause amplification
of free radical generation or that any effects were below the
detection limits of the assays used. The absence of apparent
synergism between BPO and UVB may indicate that BPO in skin
does not absorb appreciable UVB radiation. The overlap of the
BPO absorption spectrum with the UVB lamp emission spectrum
may actually not be as great as depicted in Fig 5 as the absorption
spectrum was taken on a 0.2 mM solution with a 1 cm path
length. The path length in skin is certainly much shorter and the
concentration may be lower; both of these factors would decrease
the fraction of UVB that would excite BPO molecules in skin. In
addition, multiple UVB and BPO exposures cause epidermal
hyperplasia; photon absorption in the thickened epidermis also
decreases the penetration of the shorter UVB wavelengths into the
viable skin layers.
This study examined the fluence dependence of UVB-induced
chronic effects in contrast with almost all previous studies in which
single UVB fluences were employed. As anticipated, UVB fluence-
dependent increases occurred for most skin responses (epidermal
thickness, SBC, GAG content, mast cells, and dermal thickness)
(Fig 1). An unexpected result was the low amount of elastin
(measured as desmosine) in skin treated with the highest UVB
fluence (Fig 1C). A similar smaller elastin increase (over untreated
control) despite greater stimulation was also found when BPO
treatments were combined with the low and medium UVB
treatments (Fig 4C). These results suggest that greater stimulation
during chronic exposures may increase the level of elastases and
thus decrease the net cross-linked elastin content; this hypothesis
needs further evaluation. SFT, reflecting mainly dermal thickness
and the cyst layer, increased with time and UVB fluence (Fig 2),
consistent with the increases in dermal ground substance and
inflammatory infiltrate, illustrating the dependence of these changes
on both fluence and chronicity of exposures.
In summary, the results of this study show that repeated chronic
treatment with BPO can cause changes which resemble those
caused by low fluence UVB and are quite distinct from other
chronic inflammatory skin disorders. This suggests that common
inflammatory mechanisms may be involved in the production of
the changes seen with chronic UVB or BPO exposure. It is likely
that free radical generation, alteration of anti-oxidant capacity or a
combination of both is implicated and the findings provide further
support for the role of oxidative stress in the photoaging process.
Further work, including inhibitor studies, is required to clarify the
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free radical mechanisms potentially involved. We have found no
evidence, however, to suggest a synergistic effect of BPO on the
deleterious skin changes induced by chronic UVB treatment under
the experimental conditions employed.
This work was supported by NIH grant RO1 AR43895 and a research grant
from the Procter & Gamble Company.
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